Novartis Gets CDSCO Panel Nod to Study XXB750 in Patients With Heart Failure Dr. Divya Colin2 Feb 2024 6:00 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Intas Pharma Gets CDSCO Panel Nod to Study anti-cancer Drug Lipid Based Cabazitaxel Dr. Divya Colin1 Feb 2024 6:00 PM ISTNew Delhi: Citing that the firm should include an adequate number of government hospital trial sites, the Subject Expert Committee (SEC) functional...
Novo Nordisk Gets CDSCO Panel conditional nod to study Insulin icodec Dr. Divya Colin31 Jan 2024 6:00 PM ISTNew Delhi: The drug major Novo Nordisk has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO panel nod to Sun Pharma to study of anticancer drug Leuprolide acetate for depot suspension Anshika Mishra31 Jan 2024 5:41 PM ISTThe drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Health Bulletin 31/January/2024 Anshika Mishra31 Jan 2024 4:55 PM ISTHere are the top health news for the day:HC orders Bengal Govt to establish medical board for rape survivors' pregnancy terminationIn a significant...
Sun Pharma gets CDSCO Panel Nod To study Leuprolide acetate for depot suspension Dr. Divya Colin30 Jan 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel grants Bristol Myer Squibb's Proposal for Additional Indication of anti-cancer drug Nivolumab Dr. Divya Colin30 Jan 2024 5:30 PM ISTNew Delhi: Noting that sufficient safety data is established, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Justify proposed dose and rationality: CDSCO Panel Tells Lupin on FDC Sacubitril plus Valsartan Dr. Divya Colin29 Jan 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Lupin for the fixed-dose combination (FDC) cardiovascular drug Sacubitril plus...
CDSCO panel nod to Biological E to conduct Phase II trial of vaccine for 6- 8 weeks-old infants Anshika Mishra29 Jan 2024 5:24 PM ISTReviewing the Phase I clinical trial report, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Health Bulletin 29/January/2024 Anshika Mishra29 Jan 2024 5:16 PM ISTHere are the top health news for the day:Three drug treatment regime to be introduced to stop leprosy transmission by 2027The Union Health Ministry...
Biological E gets CDSCO Panel Nod To study vaccine for 6- 8 weeks old infants Dr. Divya Colin28 Jan 2024 6:00 PM ISTNew Delhi: Reviewing the Phase I clinical trial report, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Grants Novartis Protocol Amendment Proposal For anti-cholesterol drug Inclisiran Dr. Divya Colin28 Jan 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
